QA: Amicus Therapeutics INC in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001178879_2021_Amicus_Therapeutics_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001178879, Amicus Therapeutics INC

  xvar xval
0 AssetsCurrent 579,469,000
1 IntangibleAssetsNetIncludingGoodwill 220,797,000
2 PropertyPlantAndEquipmentNet 43,863,000
3 remainder_Assets 42,391,000
4 LiabilitiesCurrent 129,676,000
5 LiabilitiesNoncurrent 51,983,000
6 remainder_Liabilities 418,481,000
7 CostOfGoodsAndServicesSold 47,038,932
8 SellingGeneralAndAdministrativeExpense 141,535,610
9 ResearchAndDevelopmentExpense 326,771,663
10 remainder_Expenses 34,090,389
11 remainder_Revenues 263,422,959
12 remainder_NetIncome -16,126,057
13 remainder_ComprehensiveNetIncome 4,334,593
  yvar yval
0 Assets 886,520,000
1 Liabilities 600,140,000
2 Expenses 549,436,594
3 Revenues 263,422,959
4 StockholdersEquity 286,380,000
5 NetIncome -302,139,692
6 ComprehensiveNetIncome -299,972,396
7 BaseVar 1,159,990,102
8 EconomicCapitalRatiobeforeLimitedLiability 0.436
9 EconomicCapitalRatio 1.83

Edgar->Model Mapping

Feature Distribution

Change over Time